Viewing Study NCT06423261


Ignite Creation Date: 2025-12-24 @ 12:32 PM
Ignite Modification Date: 2026-01-03 @ 8:45 PM
Study NCT ID: NCT06423261
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-04-09
First Post: 2024-04-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Tolerability, Pharmacokinetics and Immunogenicity Study of GB002 Recombinant Peptide Inhalation Solution in Healthy Subjects
Sponsor: Zhejiang Echon Biopharm Limited
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module